๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Hormonal therapy in the treatment of carcinoma of the prostate

โœ Scribed by David G. McLeod

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
636 KB
Volume
75
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Carcinoma of prostate: Case against imme
Carcinoma of prostate: Case against immediate hormonal therapy
โœ Smith, Philip H. ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 429 KB ๐Ÿ‘ 2 views

The Urologist is anxious to cure patients where possible and to minimize the impact of the disease where treatment is palliative. Within the pelvis atten-

Hormonal manipulation in the treatment o
Hormonal manipulation in the treatment of pancreatic carcinoma
โœ B. A. Greenway ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 137 KB ๐Ÿ‘ 1 views

Peptic ulcer surgery and colorectal cancer risk ## Sir We concur with the recently published paper by Toftgaard (Br J Surg 1987; 74: 573-5) and recent letter by Houghton and Mortensen (Br J Surg 1987; 74: 1066) that there is no statistically significant association between gastric surgery for ben

Bone fractures associated with luteinizi
Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma
โœ Murphy F. Townsend; W. Holt Sanders; Robert O. Northway; Sam D. Graham Jr. ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 78 KB ๐Ÿ‘ 2 views

## Background: Luteinizing hormone-releasing hormone agonists (lhrh-a) have become an established treatment for certain patients with prostate carcinoma. lhrh-a are known to decrease bone mineral density. the purpose of this study was to determine the risk of bone fracture in men receiving lhrh-a f